Repare Therapeutics Inc.

NASDAQ: RPTX · Real-Time Price · USD
1.56
0.00 (0.00%)
At close: Aug 15, 2025, 2:53 PM

Repare Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
53.48M 51.13M 131.83M 7.6M
Cost of Revenue
1.92M 13.24M 4.18M 3.34M
Gross Profit
40.1M 37.89M 15.11M -80.25M
Operating Income
-93.52M -116.22M -19.8M -108.66M
Interest Income
10.39M 13.33M 5.63M 259K
Pretax Income
-83.25M -103.18M -13.9M -108.59M
Net Income
-84.69M -93.8M -29.05M -106.91M
Selling & General & Admin
29.68M 33.76M 32.56M 26.21M
Research & Development
115.94M 133.59M 119.07M 90.05M
Other Expenses
-12M -13.24M -116.72M -87.85M
Operating Expenses
133.62M 154.12M 34.9M 28.41M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
147M 167.36M 151.63M 116.26M
Income Tax Expense
1.44M -9.38M 15.15M -1.68M
Shares Outstanding (Basic)
42.41M 42.09M 41.92M 37.82M
Shares Outstanding (Diluted)
42.41M 42.09M 41.92M 37.82M
EPS (Basic)
-2 -2.23 -0.69 -2.83
EPS (Diluted)
-2 -2.23 -0.69 -2.83
EBITDA
-90.22M -114.27M -17.82M -107.19M
EBIT
-92.14M -116.22M -19.8M -108.66M
Depreciation & Amortization
1.92M 1.95M 1.98M 1.47M